Full-Time

Senior Clinical Trial Manager

Updated on 8/1/2026

Bicara Therapeutics

Bicara Therapeutics

51-200 employees

Develops targeted therapies and tumor modulators

Compensation Overview

$179k - $211k/yr

Boston, MA, USA

Hybrid

Three days in-office each week; travel up to 10–20% of the time.

Category
Biology & Biotech (1)
Required Skills
Risk Management

Get referred to Bicara Therapeutics

See people who can refer or advise you

Requirements
  • A Bachelor's Degree is required, preferably in Life Sciences such as Biology, Chemistry, Biochemistry, Nursing, or Pharmacy.
  • A minimum of 5 years of clinical trial management experience in the pharmaceutical, biotechnology, or contract research organization industry is required.
  • Demonstrated ability to manage global clinical trials across regional regulatory requirements, cultural nuances, and varying site capabilities.
  • Clinical research operational knowledge, computer literacy, and strong project planning and management skills, including oversight of contract research organizations and vendors.
  • Global clinical trial management experience in a fast-paced, contract research organization-outsourced environment is required.
  • Experience and ability to manage global or regional teams in a virtual environment.
  • Strong decision-making, communication, collaboration, analytical, and issue-resolution skills are required.
  • Adaptability and willingness to work in a fast-paced environment are required.
  • Effective leadership skills and the ability to foster team productivity, cohesiveness, and quality deliverables are required.
  • Willingness to travel up to 10–20% of the time is required.
Responsibilities
  • Execute the company's clinical operations strategy for high-touch, patient-centered clinical trials, with a focus on adaptive and seamless designs supporting registration.
  • Support the clinical operations team in ensuring trial deliverables meet timelines, budgets, operational procedures, and quality standards.
  • Develop assigned sections of study documents, including sections of the laboratory manual.
  • Develop study tools, guidelines, and training materials.
  • Manage clinical study materials and implement issue-resolution plans.
  • Work closely with external collaboration partners to manage relationships and improve efficiency.
  • Lead the proactive identification, assessment, and management of clinical study challenges and risks.
  • Support oversight of study activities, including site identification and selection, enrollment models, clinical supply planning, budget planning, and trial execution.
  • Monitor study progress, including contract research organization and third-party vendors, and maintain vendor compliance with relevant regulations and guidelines.
  • Work with the contract research organization to develop or revise scopes of service agreements, budgets, plans, and detailed timelines, and ensure performance expectations are met.
  • Participate in developing and authoring study documents, including protocols, investigator brochures, and informed consents.
  • Participate in Case Report Form design and user acceptance testing with Data Management, and conduct data monitoring throughout the study.
  • Oversee study management and clinical development teams, including contract research organizations, to facilitate clinical development goals and study quality metrics.
  • Execute contract research organization and third-party oversight activities, including monitoring visit report review, periodic data-quality review, contract research organization and vendor key performance indicator review, and Sponsor Oversight Visits.
  • Contribute to or author clinical sections of regulatory documents, including Investigator Brochures, safety updates, and responses to Health Authority and Ethics Committee questions.
  • Manage a team of Clinical Trial Associates, including hiring and career and professional development, as applicable.
Desired Qualifications
  • Phase 2/Phase 3 study experience is strongly preferred.
  • Oncology study experience is strongly preferred.

Bicara Therapeutics develops cancer therapies that combine targeted precision treatment with tumor modulation. Their products deliver agents to cancer cells with high specificity while also adjusting the tumor environment to boost anti-cancer activity. This dual-action approach sets them apart from firms pursuing a single strategy, as they aim to both attack cancer cells and modify the tumor site through partnerships and regulatory navigation. The company’s goal is to improve patient outcomes by bringing effective, approvable therapies to market through research, trials, and eventual commercialization.

Company Size

51-200

Company Stage

IPO

Headquarters

Cambridge, Massachusetts

Founded

2020

Get referred to Bicara Therapeutics

See people who can refer or advise you

Simplify Jobs

Simplify's Take

What believers are saying

  • Phase 2/3 readout in HPV-negative recurrent/metastatic HNSCC creates a major catalyst.
  • $539.8 million cash extends runway into early 2029, reducing financing pressure.
  • Institutional conviction from Omega Fund Management supports partnering and follow-on funding.

What critics are saying

  • FORTIFI-HN01 failure would leave Bicara without approved products or revenue.
  • Single-asset dependence makes valuation highly sensitive to one clinical outcome.
  • Pembrolizumab controls the backbone regimen, raising efficacy hurdles for ficerafusp alfa.

What makes Bicara Therapeutics unique

  • First-in-class bifunctional EGFR/TGF-β antibody platform targets tumor cells and microenvironment.
  • Lead asset ficerafusp alfa is in Phase 2/3 for head and neck cancer.
  • Bicara is building a second program, BCA356, beyond the lead asset.

Help us improve and share your feedback! Did you find this helpful?

Benefits

Hybrid Work Options

Growth & Insights

Headcount

6 month growth

-1%

1 year growth

0%

2 year growth

1%